These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32792940)

  • 1. The Validation of Multifactor Model of Plasma Aβ
    Jiao F; Yi F; Wang Y; Zhang S; Guo Y; Du W; Gao Y; Ren J; Zhang H; Liu L; Song H; Wang L
    Front Aging Neurosci; 2020; 12():212. PubMed ID: 32792940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary levels of disease-related biomarkers in the early stages of Parkinson's and Alzheimer's disease:
    Sabaei M; Rahimian S; Haj Mohamad Ebrahim Ketabforoush A; Rasoolijazi H; Zamani B; Hajiakhoundi F; Soleimani M; Shahidi G; Faramarzi M
    IBRO Neurosci Rep; 2023 Jun; 14():285-292. PubMed ID: 36942319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline.
    Hsieh CH; Ko CA; Liang CS; Yeh PK; Tsai CK; Tsai CL; Lin GY; Lin YK; Tsai MC; Yang FC
    Front Aging Neurosci; 2024; 16():1389595. PubMed ID: 38828389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife.
    Kritikos M; Clouston SAP; Diminich ED; Deri Y; Yang X; Carr M; Gandy S; Sano M; Bromet EJ; Luft BJ
    Neurol Ther; 2020 Jun; 9(1):159-171. PubMed ID: 32350803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology.
    Lue LF; Kuo YM; Sabbagh M
    Neurol Ther; 2019 Dec; 8(Suppl 2):95-111. PubMed ID: 31833027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment.
    Weber DM; Taylor SW; Lagier RJ; Kim JC; Goldman SM; Clarke NJ; Vaillancourt DE; Duara R; McFarland KN; Wang WE; Golde TE; Racke MK
    Front Neurol; 2024; 15():1364658. PubMed ID: 38595851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment.
    Weber DM; Taylor SW; Lagier RJ; Kim JC; Goldman SM; Clarke NJ; Vaillancourt DE; Duara R; McFarland KN; Wang WE; Golde TE; Racke MK
    medRxiv; 2023 Dec; ():. PubMed ID: 38168329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACOT7, a candidate and novel serum biomarker of Alzheimer's disease.
    Wang J; Feng Y; Sun Y
    Front Aging Neurosci; 2024; 16():1345668. PubMed ID: 39026992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Storage Effects on Stability of Aβ
    Chiu MJ; Lue LF; Sabbagh MN; Chen TF; Chen HH; Yang SY
    Dement Geriatr Cogn Dis Extra; 2019; 9(1):77-86. PubMed ID: 31043966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults.
    Thompson LI; Kunicki ZJ; Emrani S; Strenger J; De Vito AN; Britton KJ; Dion C; Harrington KD; Roque N; Salloway S; Sliwinski MJ; Correia S; Jones RN
    Alzheimers Dement (Amst); 2023; 15(4):e12500. PubMed ID: 38026761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma NT1-tau and Aβ
    Stern AM; Van Pelt KL; Liu L; Anderson AK; Ostaszewski B; Mapstone M; O'Bryant S; Petersen ME; Christian BT; Handen BL; Selkoe DJ; Schmitt F; Head E;
    medRxiv; 2023 Mar; ():. PubMed ID: 36945447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzer-to-Analyzer Variations in Assaying Ultralow Concentrated Biomarkers Associated with Neurodegenerative Diseases Using Immunomagnetic Reduction.
    Lee KH; Hsu MH; Chen HH; Yang SY
    ACS Meas Sci Au; 2023 Dec; 3(6):488-495. PubMed ID: 38145030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model.
    Lin CH; Chiu SI; Chen TF; Jang JR; Chiu MJ
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
    Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
    Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.
    Janelidze S; Berron D; Smith R; Strandberg O; Proctor NK; Dage JL; Stomrud E; Palmqvist S; Mattsson-Carlgren N; Hansson O
    JAMA Neurol; 2021 Feb; 78(2):149-156. PubMed ID: 33165506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of the natural history of amyloid-β in plasma and brain.
    Burnham SC; Fandos N; Fowler C; Pérez-Grijalba V; Dore V; Doecke JD; Shishegar R; Cox T; Fripp J; Rowe C; Sarasa M; Masters CL; Pesini P; Villemagne VL
    Brain Commun; 2020; 2(1):fcaa041. PubMed ID: 32954297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease.
    Lim YY; Maruff P; Kaneko N; Doecke J; Fowler C; Villemagne VL; Kato T; Rowe CC; Arahata Y; Iwamoto S; Ito K; Tanaka K; Yanagisawa K; Masters CL; Nakamura A
    J Alzheimers Dis; 2020; 77(3):1057-1065. PubMed ID: 32925048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use.
    d'Abramo C; D'Adamio L; Giliberto L
    J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32911755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for Alzheimer's Disease Early Diagnosis.
    Ausó E; Gómez-Vicente V; Esquiva G
    J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32899797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.